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SCRIB and PUF60 Are Primary Drivers
of the Multisystemic Phenotypes
of the 8q24.3 Copy-Number Variant
Andrew Dauber,1,2,13 Christelle Golzio,3,13 Ce´cile Guenot,4 Francine M. Jodelka,5 Maria Kibaek,6
Susanne Kjaergaard,7 Bruno Leheup,8 Danielle Martinet,4 Malgorzata J.M. Nowaczyk,9
Jill A. Rosenfeld,10 Susan Zeesman,9 Janice Zunich,11 Jacques S. Beckmann,4 Joel N. Hirschhorn,12
Michelle L. Hastings,5,14 Sebastien Jacquemont,4,14 and Nicholas Katsanis3,14,*
Copy-number variants (CNVs) represent a significant interpretative challenge, given that each CNV typically affects the dosage of mul-
tiple genes. Here we report on five individuals with coloboma, microcephaly, developmental delay, short stature, and craniofacial, car-
diac, and renal defects who harbor overlappingmicrodeletions on 8q24.3. Finemapping localized a commonly deleted 78 kb region that
contains three genes: SCRIB, NRBP2, and PUF60. In vivo dissection of the CNV showed discrete contributions of the planar cell polarity
effector SCRIB and the splicing factor PUF60 to the syndromic phenotype, and the combinatorial suppression of both genes exacerbated
some, but not all, phenotypic components. Consistent with these findings, we identified an individual withmicrocephaly, short stature,
intellectual disability, and heart defects with a de novo c.505C>T variant leading to a p.His169Tyr change in PUF60. Functional testing
of this allele in vivo and in vitro showed that the mutation perturbs the relative dosage of two PUF60 isoforms and, subsequently, the
splicing efficiency of downstream PUF60 targets. These data inform the functions of two genes not associated previously with human
genetic disease and demonstrate how CNVs can exhibit complex genetic architecture, with the phenotype being the amalgam of both
discrete dosage dysfunction of single transcripts and also of binary genetic interactions.Introduction
Copy-number variants (CNV) are a potential source both
of genetic diversity1,2 and of deleterious lesions that can
drive both rare and common human disorders.3 The
now-common use of array-comparative genomic hybridi-
zation (aCGH) has increased the discovery of CNVs and
has highlighted the fact that the mechanisms that lead
to genomic rearrangements are, collectively, ~1,000 times
more prevalent per meiosis than the point mutation
rate.4 In the last decade, CNVs have been associated with
a variety of human phenotypes, including respiratory, car-
diac, renal, and craniofacial defects.5–11 Notably, CNVs are
found commonly to drive neurodevelopmental and cogni-
tive disorders.5,12–19
CNVs typically affect the dosage balance of multiple
transcripts, rendering the determination of the contribu-
tion of individual genes within each CNV to the clinical
phenotype challenging. Previous studies of recurrent,
common CNVs that used a variety of genetic tools and
model organisms have made progress in identifying
specific transcripts whose dosage imbalance can explain
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nificantly more challenging to dissect owing to the
presence of variable boundaries and thus a dearth of indi-
viduals with the same lesion.
Genomic rearrangements of the distal bands of the long
arm of chromosome 8 have been associated previously
with several clinical entities; e.g., 8q23.3 deletions in
colorectal cancer (MIM 114500)26 and Lynch syndrome I
(MIM 120435),27 8q23.3–q24.1 deletions in myoclonic ep-
ilepsy (FAME [MIM 601068]),28 8q23.2–q24.12 deletions
in microcephaly-thin corpus callosum syndrome,29 and
8q23.3–q24.13 deletions in tricho-rhino-phalangeal syn-
drome type I (Langer-Giedion syndrome, TRPS1 [MIM
190350]).30 Interstitial 8q23–q24 duplications have also
been reported, in which the affected children have cranio-
facial features, visual anomalies, and developmental
delay.31–33 Deletions are equally as rare as duplications;
8q23–q24 deletions have been described in individuals
with Langer-Giedion syndrome and were often trans-
mitted from a mosaic mother.31,34–36 Further, two individ-
uals with coloboma, intellectual disability, cardiac defects,
and craniofacial features were also reported to harbor
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Langer-Giedion syndrome region.37 Similar to other CNVs,
transitioning from detection of these events to identifying
their underlying genetic drivers is hampered by the paucity
of individuals with recurrent events and by the variability
in phenotypic expressivity. In the present study, through
the detailed analysis of a cohort with overlapping CNVs,
we narrowed the minimal critical region to a small
segment of the genome containing three genes. Systematic
functional evaluation of all three transcripts allowed us to
identify discrete contributors to the clinical phenotype
and to establish intricate genetic interactions between
two of the transcripts to modulate the expressivity of
specific endophenotypes. Further, we identified an individ-
ual with a de novo mutation in one of the two genes and,
once again through the combinatorial use of clinical
assessment and functional studies in vitro and in vivo,
were able to show that the pathology of this individual is
consistent with the predicted contribution of one of the
transcripts to the complex 8q CNV phenotype.Subjects and Methods
Subjects’ Ascertainment
Human genetic studies were approved by the institutional review
board of Boston Children’s Hospital and Centre Hospitalier Uni-
versitaire Vaudois, Lausanne. Written informed consent was
obtained from the subjects or their legal guardians for exome
sequencing, RNA studies, and use of photographs.
Knockdown, Rescue Experiments, Alcian Blue
Staining, Filtration Assay, and Embryo Manipulations
The splice-blocking morpholinos against scrib and puf60awere de-
signed and obtained from Gene Tools: scrib MO (50-GTGGCA
CAAAAGTTTGCATACCATT-30) targeting the second exon-intron
junction and puf60a MO (50-TGCAGCAGCCGCCCCTCACCTA
TAA-30) targeting the fifth exon-intron junction. Control morpho-
lino was the scrambled nucleotide sequence from Gene Tools (50-
CCTCTTACCTCAGTTACAATTTATA-30). We injected 0.5 nl of
diluted morpholino (4 and 4.5 ng for scrib and puf60aMO, respec-
tively) and/or RNA (100 pg) into wild-type zebrafish embryos at
the 1- to 2-cell stage. Injected embryos were scored and classified
into two groups, normal and mutant, on the basis of the pheno-
type compared with age-matched controls from the same clutch.
For RNA rescue and overexpression experiments, the human
wild-type mRNAs were cloned into the pCS2 vector and tran-
scribed in vitro with the SP6 Message Machine kit (Ambion). All
the experiments were repeated three times and we ran a t test or
a Pearson’s chi-square test (c2) to determine the significant differ-
ences of the morphant phenotype. Suppression of endogenous
message was shown by PCR amplification of cDNA reverse tran-
scribed from extracted total mRNA (puf60a and scrib primers are
listed in Table S1 available online). Alcian blue staining of cartilag-
inous structures was performed for investigating the morphology
of the head. Zebrafish embryos were fixed with 4% paraformalde-
hyde (PFA), and the cartilage structures were visualized by Alcian
blue staining as previously described.38 The glomerular filtration
assay was performed as follows: at 2 days postfertilization (dpf),
FITC-labeled 50 kDa dextran (Molecular Probes) was injected
into the cardiac venous sinus. For this injection, zebrafish wereThe Americananesthetized in a 1:20 to 1:100 dilution of 4 mg/ml Tricaine
(MESAB: ethyl-m-aminobenzoate methanesulfonate, 1%
Na2HPO4 [pH 7.0]) (Sigma-Aldrich) and positioned ventral side
up in a 1% agarose injection mold. After the injection, fish were
returned to egg water for recovery.
Plasmids
To make pTT3-PUF60L-His169Tyr, the plasmid with the PUF60
His169Tyr mutation, pTT3-HisPUFL, was used as a template in a
QuickChange Lightning Site-directed mutagenesis kit (Agilent)
with primers PUF60-His169Tyr-F and PUF60-His169Tyr-R (Table
S1). The plasmid, pTT3-PUF60Lrm, and pTT3-PUF60Lrm-His169
Tyr were engineered with pTT3-PUF60L or pTT3-PUF60L-His169
Tyr as a template in overlap-extension PCR reactions identical to
the method used to make pMarx-PUF60rm.39
Cell Culture
HeLa cells were transfected with pTT3 empty vector, pTT3-
PUF60Lrm, or pTT3-PUF60Lrm-His169Tyr and 20 nM of siRNA
via Lipofectamine 2000 (Invitrogen). The siRNAs used were
PUF60 r(GCAGAUGAACUCGGUGAUG)dTdT (sense strand,
Dharmacon) and Allstars negative control siRNA (QIAGEN; cat.
#1027281). After 72 hr cells were harvested for RNA by TRIzol re-
agent (Life Technologies) and protein by Laemmli buffer.
RT-PCR
RNA from affected individuals was collected with PAXgene tubes
from peripheral blood. RNA from cell culture experiments was
collected with TRIzol reagent (Invitrogen). Reverse transcription
was performed with GoScript (Promega) with oligo dT primers.
PCR with GoTaq polymerase (Promega) was carried out in reac-
tions containing a-[32P]dCTP. Primers sequences are provided in
Table S1. Products were separated on 6% native polyacrylamide
gels. Quantitation is based on phosphorimage analysis (Typhoon
9400; GE Healthcare).
Immunoblot
Protein samples were separated by SDS-PAGE and transferred
to Immobilon-FL membrane (Millipore). Blots were probed
with mouse monoclonal antibodies specific for PUF60 (generated
by M.L.H.) or b-actin (Sigma), followed by Alexa Fluor 594-con-
jugated antimouse secondary antibody (Invitrogen) or horseradish
peroxidase (HRP)-conjugated goat anti-mouse antibody. Detection
and quantitation of the signal was performed with a Typhoon
9400 Variable Mode Imager (GE Healthcare) and ImageQuant
T software for fluorescently detected blots or with Lumi-Light
Western Blotting Substrate (Roche Diagnostics) for HRP-labeled
blots.
Exome Sequencing
Whole-exome sequencing of subject 6 and her parents was
performed at the Broad Institute. Hybrid selection was performed
with Agilent’s SureSelect Human All Exon Kit v.2 (Agilent Tech-
nologies). We sequenced the samples with the Illumina HiSeq
2000 platform (Illumina) and aligned the resulting reads to the
UCSC Genome Browser (hg19) reference genome with Burrows-
Wheeler Aligner. We then applied the Genome Analysis Toolkit,
base quality score recalibration, and indel realignment and per-
formed single-nucleotide polymorphism and indel discovery and
genotyping across all samples simultaneously by using variant
quality score recalibration. Variants were annotated for functionalJournal of Human Genetics 93, 798–811, November 7, 2013 799
Figure 1. Positions of the 8q24.3 Deletions and the Corresponding Photographs of Affected Individuals
(A) Schematic representation of chromosome 8 showing the breakpoints of the 8q24.3 deletions. The minimal deletion (individual 1)
includes SCRIB, PUF60, and NRBP2.
(B) Photographs of individuals 1–5 capture the core facial gestalt, including microcephaly, bitemporal narrowing, wide nasal bridge,
anteverted nares, long and flat philtrum, and thin upper lip.effect by SnpEff 2.0.5. Variants were filtered as previously
described.40Results
Clinical Assessment and Fine Mapping
We studied five individuals (individuals 1–5, Figure 1, Ta-
ble 1) with a de novo interstitial 8q24.3 deletion ranging
from 78 kb to 1 Mb, all of which contained the previously
reported deletion.37
Individual 1
This 10-year-old girl was the second child of healthy non-
consanguineous parents. The family history revealed no
stillbirths, intellectual disability, or birth defects. Abdom-
inal ultrasound showed a left renal agenesis. On physical
examination at the age of 10 years, growth retardation
and microcephaly were noted (weight: 22 kg, <3rd percen-
tile; height: 125 cm, <3rd percentile; head circumference:
49 cm, <3rd percentile). Facial features included bilateral
iris coloboma noted at birth, retrognatism, bilateral preaur-
icular pits, long philtrum, thin upper lip, anteverted nares,
and coarse hair (Figure 1). The association of middle ear
malformations and renal agenesis prompted the molecular
analysis of EYA1, which showed an intronic variant
(c.16983C>T) that was considered nonpathogenic. Anal-
ysis of PAX2 was also performed because of the association
of renal agenesis and bilateral coloboma and was normal.
The karyotype was normal (46,XX). Array CGH analysis800 The American Journal of Human Genetics 93, 798–811, Novemb(Agilent 244 K) revealed a deletion of 65 to 78 kb on chro-
mosome 8q24.3 (chr8: 144,868,670–144,933,911) (UCSC
Genome Browser hg19). This deletion was absent in both
parents.
Individual 2
This 6-year-old boy was the second child of nonconsan-
guineous parents. The family history revealed no
stillbirths, intellectual disability, or birth defects. His
growth was regular but below the 3rd percentile. He
showed a moderate motor and speech delay. He had
recurrent pneumonia, upper respiratory tract infections,
and febrile seizures. He also had apnoeic episodes possibly
resulting from esophageal reflux associated with a small
hiatus hernia. At birth, bilateral coloboma of the iris,
choroid, and retina without involvement of the optic
nerves was noted. The vision was normal. The CT scan
of the brain at 9 months and the MRI of the brain at
19 months showed slight temporal and frontal cerebral
atrophy. On physical examination at the age of 2 years,
growth retardation was noted (weight, –1 SD; height,
2 SD; head circumference, 1 SD). Facial features
included bitemporal narrowing, long eyelashes, a flame
nevus of the eyelids, short nose, anteverted nares, long
philtrum, thin upper lip, full cheeks, and short neck
with loose skin (Figure 1). He also had a single palmar
crease and proximal placement of thumbs. Karyotype
was normal (46,XY). Array CGH analysis (Agilent 244 K)
revealed a 0.98 Mb (minimal size) deletion on chromo-
some 8q24.3 (chr8: 144,614,025–145,690,359) (UCSCer 7, 2013
Table 1. Phenotypes of the Five Individuals with 8q24.3 Deletions
Clinical Features Individual 1 Individual 2 Individual 3 Individual 4 Individual 5 Individual 6 Verheij, 1
Coloboma þ þ no no no no þ
Renal þ no þ þ þ no no
Low birth weight þ no þ þ no þ þ
Growth retardation þ þ þ þ þ þ þ
Microcephaly þ þ no no þ þ no
Vertebral anomalya þ no þ no þ þ no
Developmental delay no þ þ þ þ þ þ
Hand anomaliesb no no no þ þ þ þ
Feeding problems no no þ þ þ no þ
Joint laxity and/or
dislocationc
no þ þ þ þ þ þ
Long philtrum þ þ þ þ þ þ þ
Micro/retrognatism þ no no no no þ þ



















Size of deletion (MB) 0.078 1 1 0.69 0.55 p.His169Tyr 15.1
Break points proxd 144,868,670 144,614,025 144,768,060 144,747,447 144,159,121 none 130,370,818
Break points distd 144,933,911 145,690,359 145,847,409 145,535,208 145,573,790 none 145,569,192
aSacral dysplasia, coccyx agenesis, fusion of L5-S1, hemivertebrae.
bShort fifth fingers, clinodactyly, ectrodactyly (right thumb), postaxial polydactyly.
cHip dislocation unilateral/bilateral, left elbow subluxation.
dUCAC Genome Browser hg19 coordinates.Genome Browser hg19). The deletion was confirmed by
real-time PCR and investigations of parental samples
showed that the deletion was de novo.
Individual 3
This 17-year-old girl was the second child of nonconsan-
guineous parents. The family history revealed no
stillbirths, intellectual disability, or birth defects. A truncus
arteriosus type I associated with ventricular septal defect
was diagnosed at birth. Her growth was regular but below
the 3rd percentile. She smiled at 3 months, sat at
14 months, and walked at 28 months. She started to speak
at 8 years of age and was still not reading nor writing at the
age of 15 years. She had left polycystic kidney, fusion of L5-
S1, and left elbow subluxation with malformation of the
great sigmoid cavity. The brain MRI at the age of 15 years
was normal. At 15 years of age, height was at 3.5 SD,
BMI at þ2.5 SD, and head circumference at 0 SD. Facial
features included a prominent forehead, slight synophris,
high and narrow palate, slight prognatism, bulbous nose
tip, anteverted nares, and thin lips (Figure 1). Karyotype
was normal (46,XX). Array CGH analysis (Agilent 105 K)
revealed a 1 Mb deletion on chromosome 8q24.3 (chr8:
144,768,060–145,847,409) (UCSC Genome BrowserThe Americanhg19). Investigations by FISH of parental samples showed
that the deletion was de novo.
Individual 4
She was the only child of nonconsanguineous and healthy
parents. The family history revealed no stillbirths, intellec-
tual disability, or birth defects. Her growth was regular but
below the 3rd percentile. She sat at 6–7 months and walked
at 18 months. She had fewer than 10 words at 20 months
and started to speak in sentences at 36 months. Investiga-
tions for short stature showed a normal growth hormone
stimulation test, normal thyroid hormone status, and a de-
layed bone age (at the chronological age of 9 years and
1 month, the bone age was 6 years and 10 months). She
had feeding problems. At the age of 4 months she was
found to have ectopic fused kidneys after investigations
for urinary tract infection. The MRI of the brain at the
age of 2 years and 10 months showed small areas of ence-
phalomalacia over the anterior part of the left cerebellar
hemisphere and inferior vermis originating from an old
ischemic event within the area served by the posterior infe-
rior cerebellar artery. On physical examination at the age of
20 months, growth retardation was noted (weight, 3.5
SD; height, 2nd percentile; head circumference, 50thJournal of Human Genetics 93, 798–811, November 7, 2013 801
percentile). Facial features included bitemporal narrowing,
tall and narrow forehead, wide nasal bridge, anteverted
nares, long philtrum, thin upper lip, wide palpebral fissure,
bilateral preauricular pits, and a capillary hemangioma in
the middle of her forehead (Figure 1). Karyotype was
normal (46,XX). Array CGH analysis (GenomeDx micro-
array v.3.1) of the affected individual and parents revealed
a de novo 688 kb deletion on chromosome 8q24.3 (chr8:
144,747,447–145,535,208) (UCSC Genome Browser
hg19).
Individual 5
This 11-year-old girl was the second child of healthy non-
consanguineous parents. The family history revealed no
stillbirths, intellectual disability, or birth defects. Dysmor-
phic features were noted at birth: bitemporal narrowing
with trigonocephaly, bilateral epicanthal folds, broad
nasal root, depressed nasal tip, long philtrum, short
neck with excess neck skin posteriorly, clinodactyly, bilat-
eral transverse palmar creases, sacral dimple, and bilateral
dislocated hips. Between 1 and 2 months, she experienced
respiratory distress. Hemivertebrae were diagnosed on
chest X-ray and ventricular septal defect associated with
aorta coarctation on echocardiography. She suffered reflux
and tracheomalacia until 7 months old and received naso-
gastric feeding for 6 months. She suffers from severe cyclic
vomiting since the age of 3. At 1 year, she was diagnosed
with right kidney hypoplasia, solitary renal cyst in this
kidney, scoliosis, and joint hypermobility. She showed
moderate motor and speech delay. She was diagnosed
with hyperopia at the age of 3 and seizures at the age of
9. The MRI of the brain at the age of 6 and 7 years noted
volume loss in the left temporal lobe. At 10 years of age,
her growth remained regular below the 3rd percentile for
all parameters (microcephaly). Facial features included
cranial asymmetry with right occipital flattening, broad
nasal root, long and flat philtrum, thin upper lip, short
broad neck with low posterior hairline, bilateral epican-
thal folds, bilateral transverse palmar creases, and short-
ening of the 5th digit with 5th finger clinodactyly
(Figure 1). Karyotype was normal (46,XX). Array CGH
analysis (GenomeDx microarray v.3.1) revealed a 0.55
Mb (minimal size) deletion on chromosome 8q24.3
(chr8:144,159,121–145,573,790) (UCSC Genome Browser
hg19). This deletion was not present in either parent by
FISH analysis.
The minimal common deletion (Figure 1; Table 1)
encompassed three genes: SCRIB (scribbled homolog
[MIM 607733]), NRBP2 (nuclear receptor binding protein
2), and PUF60 (poly-U binding splicing factor 60 kDa
[MIM 604819]), raising the possibility that haploinsuffi-
ciency of some or all these three genes might give rise to
the observed phenotypes.
In Vivo Testing of Minimal CNV Genes
Manipulation of zebrafish has enhanced our understand-
ing of the function of point mutations in human genetic
disorders38,41–46 (also see review47). More recently, this802 The American Journal of Human Genetics 93, 798–811, Novembmodel has also been used to investigate human dosage-
sensitive genes involved in CNV-induced phenotypes,
wherein suppression and/or overexpression of each gene
within the CNV, followed by binary epistatic tests, can
facilitate the dissection of CNV-associated defects.20,48
We therefore asked whether we could examine systemati-
cally the potential contribution of the three genes within
the minimal 8q24.3 CNV for anatomic traits by assaying
the organ systems relevant to the human pathology with
objective measurements. We first queried the zebrafish
genome for each of the three genes; we identified a single
ortholog each for SCRIB and PUF60 (60% identity for scrib
[NM_001007175.1] and 82% identity for puf60a
[NM_001105588.1]) and two orthologs for NRBP2 (62%
and 61% identity for nrbp2, [XP_001920672.2] and
NRBP2 (2 of 2) [XP_005163579.1], respectively). Next, we
generated splice-blocking morpholinos (MOs) against
each of scrib, nrbp2 (both copies), and puf60 and injected
embryos at the two-cell stage, followed by phenotyping
of key anatomical hallmarks of the CNV. Suppression of
either copy of nrbp2 did not give any appreciable pheno-
types, whereas a concomitant double suppression led to
either phenotypically normal embryos at low MO doses
or global delay and embryonic lethality with no organ-
specific phenotypes at higher doses (n ¼ 80 embryos, 3
independent experiments, scoring at 3 dpf). As such,
although a definitive statement about this gene cannot
be made with regard to its contribution to the phenotypes
of the individuals studied here, we consider this transcript
unlikely to be a primary driver of the discrete pathology of
this CNV.
In contrast, injection of 4 ng of scrib MO or 4.5 ng of
puf60 MO recapitulated multiple 8q24.3 CNV-associated
phenotypes. Injection of MO followed by RT-PCR testing
of whole embryo lysates showed the inclusion of intronic
sequences for both scrib and puf60a messages at 4.5 dpf,
thus confirming the efficiency of the splice-blocking MO
(Figure S2). First, given that short stature has been observed
in our individuals with 8q24.3 deletions (Table 1), we
measured the body length of 3 dpf embryos injected
with either scrib or puf60 MOs. We observed a modest
but significant and reproducible reduction of body length
of each of scrib and puf60 morphants compared to sham-
injected embryos (5% reduction, p ¼ 0.003; and 12%
reduction, p < 0.0001, respectively) (Figure 2A).
Second, because three out of five of the individuals
studied here are microcephalic, we asked whether SCRIB
and/or PUF60 might be involved in the regulation of
head size. By using previously established methods of
masked scoring of embryos at 5 dpf,20,38 we observed sig-
nificant microcephaly in each of scrib and puf60 mor-
phants compared to controls (p < 0.0001) (Figures 2B
and 2C). Neither the body length nor the head size pheno-
types were likely driven by gross developmental delay;
morphants were normal with regard to the development
of the swim bladder and pigmentation. Moreover, both
the body length and microcephaly phenotypes wereer 7, 2013
Figure 2. Suppression of scrib and puf60 in Zebrafish Leads to Short Stature, Small Head Size, and Craniofacial Defects
(A) Quantification of total body lengthwas performed in embryo batches injectedwith sham (control), scribMO, puf60aMO, and double
MOs. Bars represent the mean length of 80 embryos at 3 dpf per condition, which were scored blind to injection cocktail.
(B) Lateral and dorsal views of representative control embryos and embryos injected with scrib or puf60aMO at 5 dpf; yellow line indi-
cates the distance across the convex tips of the eye cups. Right panel, ventral views of corresponding embryos stained with Alcian blue at
5 dpf to visualize cartilage structures; yellow line indicates distance between ceratohyal (CH) and Meckel’s cartilages (MK).
(C and D) Quantification of head size (C) and craniofacial defects (D) was performed in control and embryo batches injected with scrib or
puf60aMO by measuring distances as shown by the yellow lines in (B). Head size measurements are represented as a normal probability
distribution curve in which the y axis represents the probability that the values of x fall within a certain interval.
(C) Significant differences were observed for the microcephaly phenotype; p < 0.0001 between control and puf60amorphants and p <
0.0001 between control and scrib morphants (three independent experiments; two-tailed t test comparisons).
(A andD) Data are shown as the standard error of themean, SEM from three independent experiments, n¼ 80 embryos. The correspond-
ing p values are denoted on the bar graphs (two-tailed t test comparisons).specific; they could each be rescued with coinjection of
wild-type human full-length mRNAs (Figure S3).
Third, individuals with 8q24.3 deletions share craniofa-
cial defects, with retrognathia being common across the
cohort (Table 1). To test for this phenotype, we stained 5
dpf MO-injected embryos with Alcian blue and performed
quantitative morphometric analyses of the cartilage of the
jaw as described.38 We observed a significant reduction
of the distance between the Meckel’s and ceratohyal
cartilages for each of scrib and puf60 morphants, which
indicated a reduced jaw size compared to sham-injected
embryos (p < 0.0001) (Figures 2B and 2D).
Other phenotypes were unique to either scrib or puf60
morphants. Suppression of scrib resulted in coloboma, a
phenotype observed in two out of six of the affected indi-
viduals, consisting of an absence of closure of the iris in
one or both eyes in 53% of the embryos at 3 dpf; none
of the embryos injected with puf60 MO showed thisThe Americanphenotype (Figure 3A). Further, four out of five of the indi-
viduals studied here have reported renal abnormalities,
prompting us to perform a glomerular filtration assay, in
which we injected 50 kDa FITC-labeled dextran into the
cardiac venous sinus at 2 dpf followed by imaging at 5
dpf as described.49,50 Diffusion of the dextran throughout
the body and gross edema often reflect the loss of the
embryo’s ability to maintain fluid homeostasis.50 We
observed gross edema and abnormal diffusion of dextran
in 32% of scrib morphants; by contrast, all puf60 mor-
phants were indistinguishable from controls (Figure 3B).
We observed similarly restricted phenotypes for PUF60 as
well; assessment of heart edema as an established surrogate
of cardiac structural defects,51–54 a phenotype present in
two out of six of the affected individuals, showed scrib
embryos to be indistinguishable from controls, and 34%
of puf60 MO-injected embryos exhibited heart edema
(Figure 3C).Journal of Human Genetics 93, 798–811, November 7, 2013 803
Figure 3. Suppression of scrib or puf60 in Zebrafish Lead to Unique Phenotypes
(A) Lateral views of representative control (sham-injected) embryos and those injected with scribMO at 3 dpf. Coloboma was detected in
scrib morphants (black arrow) but was absent in puf60a morphants.
(A0) Corresponding quantification of the coloboma phenotype in control, scrib, and puf60amorphants. There is no statistical difference
between scrib morphants and the double morphants; ~50% of the scrib and double morphants have coloboma.
(B) Lateral views of representative control embryos and those injected with scribMO at 5 dpf. 50 kDa FITC-labeled dextran was injected
in the cardiac venous sinus at 2 dpf followed by imaging. At 5 dpf Scribmorphants have pericardiac/yolk edema and absence of dextran
in the intersegmental vessels compared to control.
(B0) Qualitative scoring of the glomerular filtration was performed in control and embryo batches injected with scribMO or puf60aMO
(n ¼ 25, Dextran-injected embryos at 2 dpf followed by scoring at 5 dpf).
(C) Lateral views of representative control embryos and those injected with puf60a MO at 3 dpf.
(C0) Qualitative scoring of heart edema was performed in embryo batches injected with scrib, puf60a, and double MOs (80 embryos per
injection cocktail).Combinatorial Effect of Gene Suppression
Taken together, our data suggest that suppression of scrib
or puf60 can induce phenotypes likely relevant to the com-
ponents of the 8q24.3 syndromic presentation. Some phe-
notypes were found upon suppression of either gene (head
size, craniofacial defects, short stature), whereas others
were specific for one or the other transcript (scrib for colo-
boma and renal defects; puf60 for cardiac anomalies). We
therefore asked whether combinatorial suppression of scrib
and puf60 might have an additive or multiplicative effect.
To test this possibility, we coinjected scrib and puf60 MOs
into zebrafish embryos and asked whether we could804 The American Journal of Human Genetics 93, 798–811, Novembobserve genetic interaction. We observed no changes in
penetrance or expressivity for coloboma, cardiac, head
size, retrognathic, or renal defects compared to zebrafish
receiving a single MO injection (Figures 3A, 3C, and 4).
However, coinjection of scrib and puf60 MOs increased
the severity of the short stature phenotype from
1,300 mm body length for scrib MO and 1,220 mm for
puf60 MO alone to 1,175 mm for the double MOs (p ¼
0.012) (Figure 2A). Taken together, our data suggest a com-
plex genetic architecture for the clinical phenotype associ-
ated with the minimal 8q24.3 deletion, wherein several
phenotypes could be induced by the loss of either SCRIBer 7, 2013
Figure 4. Puf60 p.His169Tyr Is Nonfunc-
tional in Splicing
(A) Immunoblot analysis of PUF60 in ly-
sates from cells transfected with a nonspe-
cific control siRNA (siC) or a siRNA specific
for PUF60. Cells were cotransfected with
an empty expression plasmid (C) or a
plasmid expressing wild-type PUF60
(PUF) or PUF60 p.His169Tyr mutant
(PUFm). Both PUF60 cDNA expression
plasmids have silent mutations introduced
into the siPUF target region to render them
insensitive to siRNA silencing. Blots were
probed with an Alexa 594-tagged second-
ary antibody and quantitated with a
Typhoon phosphorimager (right). Error
bars represent SEM (n ¼ 4); *p < 0.05
(two-tailed, paired Student’s t test). Blots
were subsequently probed with an HRP-
labeled secondary antibody (left). b-actin
is included as a loading control. Asterisk
indicates an SDS-resistant PUF60 dimer.
(B) Representative images of radiolabelled
RT-PCR analysis of SMN2, BIN1, and APP
alternatively spliced RNA isolated from
cells treated as described in (A).
(C) Quantitation of alternative splicing
shown in (B) by a Typhoon phosphorim-
ager. Error bars represent standard error
(n ¼ 6). Asterisk (*) indicates statistically
different from siPUF rescued with PUF60,
and hatch sign (#) indicates statistically
different from equivalently treated siC
(ANOVA with Tukey post-test).or PUF60, other phenotypes could be driven exclusively by
a single transcript, and one phenotype could be exacer-
bated from the genetic interaction of both genes.
A De Novo Mutation in PUF60 Causes 8q CNV
Endophenotypes
We reasoned that if this model is correct, individuals with
heterozygous loss-of-function mutations in either SCRIB
or PUF60 should manifest the above-defined phenotypic
components. In parallel to and independent of the CNV
dissection, we exome sequenced an individual with devel-
opmental delay, microcephaly, and craniofacial and car-
diac defects but no coloboma or renal defects (individual
6, Table 1) and we identified a de novo c.505C>T muta-
tion leading to a p.His169Tyr change in PUF60 (RefSeq
accession number NM_078480.2; GI, 402794025). This
21-year-old girl was treated in her early years for severe
growth retardation. Because of her slow interval growth,
she was given a course of growth hormone treatment,
which resulted in increased growth velocity. She was
noted to have several orthopedic anomalies: she was
born with bilateral hip dislocation corrected with Pavlik
Harness. Because of a lumbar hemivertebra and tethered
cord-inducing severe scoliosis, she underwent L4-S1 lami-
notomies and removal of tethered cord at 8 years of age
and resection of fatty filum and fusion of T4-L5 to treatThe Americanthe scoliosis at 13 years of age. Her other dysmorphic
features included hemifacial microsomia, retrognathia,
submucosal cleft palate, short neck, right arm and hand
shorter/smaller than the left ones, pes planus, an absent
right thumb, hypoplastic metacarpal and scaphoid bones,
and malar hypoplasia (Figure S1). On her last physical ex-
amination at the age of 20 years, she demonstrated severe
short stature with a height of 128.7 cm (5.31 SD),
weight 38.2 kg (3.34 SD), and BMI 23.1 kg/m2
(0.5 SD). She had marked microcephaly with a head
circumference of 50 cm (4.1 SD). Her global develop-
mental delay affected cognitive, behavior, and physical
growth. She was able to sit at 3 years and walk at 5 years
of age. She is nonverbal but is able to communicate with
rudimentary sign language. She developed seizures at 9
years of age, controlled with antiepileptic therapy. She
was noted to have a ventricular septal defect that closed
spontaneously along with a bicuspid aortic valve. The
MRI of the brain at the age of 12 years noted slight
enlargement of the third and lateral ventricles with a
thin corpus callosum and microcephaly. She had no large
CNVs but did have a 13.946 kb intronic deletion
(COL5A2; chr2: 189,993,689–190,007,634). This lesion is
unlikely to be relevant to the phenotype.
The allele affects a highly conserved residue (Figure S5)
and was absent from all control data sets, including 1000Journal of Human Genetics 93, 798–811, November 7, 2013 805
Figure 5. In Vivo Data: Individuals’ RNA and Zebrafish
(A) Deregulation of PUF60-dependent alternative splicing in
affected individuals. Quantitation of RT-PCR analysis of alterna-
tively spliced mRNA isoforms from SMN2, PUF60, BIN1, and APP
from relatives (n ¼ 6) or proband (n ¼ 4) with a mutation or dele-
tion of PUF60.
(B) Quantification of the total body length was performed in
embryo batches injected with puf60a MO alone or puf60a MO
along with either human wild-type (WT) or mutant PUF60
(p.His169Tyr) messages. The p.His169Tyr mutation was intro-
duced in the long and short isoforms. Bars represent the average
length of 80 embryos at 3 dpf, which were scored blind to injec-
tion cocktail. Injection of long WT and mutant mRNAs rescued
the body length phenotype observed in puf60a morphants (p <
0.0001; two-tailed t test comparisons). The short mutant PUF60
mRNA failed to rescue the phenotype and showed no significant
difference with the embryos injected with the puf60a MO alone.
Data are shown as the mean 5 SEM (three independent experi-
ments). Hatch sign (#) indicates nonsignificant.Genomes, ESP, and internal controls, and is predicted to be
damaging with a Polyphen2 score of 0.999.
Our CNV dissection data predict that, based on the
phenotype, the p.His169Tyr allele would have a loss-of-
function effect on the protein. To test this possibility, we
first knocked down PUF60 expression in HeLa cells by
using siRNA and assayed quantitatively the splicing of
BIN1, APP, and SMN2, all of which are known to be differ-
entially spliced based on PUF60 function.39 We then asked
whether plasmids expressing 169His or 169Tyr, with addi-
tional silent mutations engineered to render them insensi-806 The American Journal of Human Genetics 93, 798–811, Novembtive to RNAi, could rescue that phenotype. Knockdown of
PUF60 led to significant changes in these genes’ mRNA
splicing profiles. Specifically, upon knockdown of the
endogenous PUF60, we observed an increase of the SMN2
exon 7 splicing (ratio of exon 7 included/Dexon 7) and
more skipping of APP exons 7 and 8 (ratio D7D8/FLþD8)
compared to control cells transfected with the sham siRNA
(siC) (Figures 4A–4C). We also observed a decrease of the
BIN1 full-length transcript in the absence of PUF60 (Figures
4B and 4C). These splicing changes could be rescued by
wild-type but not mutant PUF60 (p < 0.05) (Figures 4B
and 4C).
To explore this effect directly in our cohort, we extracted
whole-blood RNA from the individual with the p.His169
Tyr change (individual 6), from three individuals with
8q24.3 deletion (individuals 1, 2, and 4), and from six un-
affected family members. We found similar patterns of
alternative splicing affecting SMN2 and APP, but not
BIN1, in individuals with the deletion compared to con-
trols as were seen in the in vitro knockdown experiments
(p ¼ 0.0002 and p ¼ 0.054 for SMN2 and APP, respectively)
(Figure 5A). Strikingly, the splicing of PUF60 itself was
affected in all three individuals with 8q24.3 deletion, as
well as in individual 6, in whom exon 5 was skipped
more frequently compared to unaffected family members,
with a net result of the individual producing less of the
long isoform of PUF60 (p ¼ 0.04) (Figure 5A).
As a final test, we sought to evaluate the relative func-
tionality of the long and short isoforms of PUF60 in vivo
with regard to the phenotypes seen to be driven by the
PUF60 mutation or deletion. We therefore engineered the
two PUF60 isoforms and introduced the 169Tyr allele in
both of them. We then coinjected zebrafish embryos
with puf60 MO and either wild-type (WT) or mutant
mRNAs and measured the body length at 3 dpf (80
embryos/injection, masked to the injection cocktail). We
observed a significant rescue of the body length phenotype
in WT coinjections and in coinjections with the 169Tyr
mutant on the long PUF60 isoform (p < 0.0001). In
contrast, the short mutant isoform of PUF60 failed to
rescue the phenotype (Figure 5B). Together with the
in vitro data, these findings suggest that the p.His169Tyr
change is a loss-of-function allele that perturbs the splicing
patterns of PUF60 itself, biasing the locus toward pro-
duction of a short splice isoform. Critically, this bias is
probably relevant to the pathology, given that the human
phenotypes approximated in puf60 morphants could be
rescued only by the long human PUF60 isoform.Discussion
In contrast to recurrent CNVs that are mediated by nonal-
lelic homologous recombination and thus have typically
fixed boundaries, rare, nonrecurrent CNVs present a vex-
ing interpretative problem. Here we have shown that by
combining clinical assessment, genomic and geneticer 7, 2013
analyses, and systematic functional studies of all genes
within the minimal CNV region, it is possible to determine
the contribution of dosage imbalance of each transcript to
the phenotype. Our studies suggest that haploinsuffi-
ciency of SCRIB and PUF60 drive the majority of the syn-
dromic phenotypes found in our individuals with the
8q24.3 CNV.
Papillorenal syndrome (RCS [MIM 120330]) is character-
ized by optic nerve dysplasia (coloboma) and renal malfor-
mations. To date, PAX2 mutations (MIM 167409) have
been the only identified genetic cause associated with
RCS, but mutations remain unidentified in ~50% of
RCS-positive individuals. Notably, individual 1, harboring
the minimal 8q24.3 deletion including SCRIB, exhibits
coloboma and renal malformations. PAX2 and SCRIB
share a similar major role in planar cell polarity (PCP),
so SCRIB thus appears as a potential candidate gene for
RCS considering the phenotypic overlap between RCS
and the 8q24.3 deletion-associated phenotypes. The
scribble complex, containing scribble (the Drosophila
ortholog of the human SCRIB), lethal giant larvae (Lgl),
and discs large (Dig), localizes to the lateral surface in
polarized epithelia.55 Scribble also regulates cell-cell inter-
action56 and endothelial cell migration.57 Requirement of
scribble has been reported in the formation of the pro-
nephros by controlling the renal epithelial polarity via
the procadherin Fat1 and Hippo signaling.58 The presence
of scribble is required in PCP establishment during the
development of the Drosophila eye and wing.59 Defective
PCP signaling has been associated previously with micro-
phthalmia and retinal coloboma exemplified by the pres-
ence of coloboma in Frizzled560–62 and Lrp663 knockout
mice (with 50% and full penetrance, respectively). Finally,
scribble plays a role in synaptic plasticity and synaptic
vesicle dynamics64 and promotes cell polarization during
astrocyte migration.65
A retrospective evaluation of the clinical phenotype of
individual 6, as well as of the PUF60-driven phenotypes
of the CNV carriers, suggested a striking overlap with
Nager syndrome (MIM 154400) and mandibulofacial dys-
ostosis with microcephaly (MFDM [MIM 610536]). Nager
syndrome and MFDM are due to haploinsufficiency in
SF3B4 (MIM 605593) and EFTUD2 (MIM 603892), both
encoding proteins with a key role in splicing.66–69 SF3B4
is a component of U2 snRNP and EFTUD2 is a U5 snRNP
protein.70 PUF60 encodes an additional splicing factor,
which interacts directly with SF3B439 and plays a role in
the recognition of the 30 splice site during splicing and
recruitment of U2 snRNP and subsequently U5 snRNP to
the intron for splicing. Taken together, our data suggest
that Nager syndrome, MFDM, and now PUF60 deficiency
all lead to a spectrum of disorders resulting from partial
ablation of spliceosome function.
Experimental animal models, including the zebrafish
experiments described here, support the notion that indi-
vidual cell types and developmental events may require
differential PUF60 expression, possibly because of a roleThe Americanfor PUF60 in the alternative splicing of specific gene tran-
scripts. The Drosophila ortholog of PUF60, pUf68 (HFP), is
required for normal development.71 Hypomorphic females
produce short eggs with defects in germline mitosis,
nuclear morphology, and dorsal ventral patterning
possibly resulting from observed defects in developmen-
tally regulated alternative splicing.71 PUF60 may have a
partially redundant function in constitutive splicing, as
previous studies have shown,39 but may be specifically
required for the splicing of a subset of tissue-specific
splicing events that, when deregulated in the absence of
PUF60, affect the development of organs such as the brain,
heart, kidney, and the eye.
Our studies also contribute to emerging theme of
complex genetic architecture of CNVs with regard to the
contribution of genes to the phenotype. Here, haploinsuf-
ficiency of each of SCRIB or PUF60 contribute uniquely to
specific endophenotypes (e.g., coloboma, heart defects),
and binary interaction potentially exacerbates other as-
pects of the clinical pathology of individuals with 8q24.3
deletion. We speculate that this genetic architecture will
be common in both recurrent and nonrecurrent CNVs.
Although the number of CNVs dissected to date is modest,
KCTD13 (MIM 608947) has been shown to be the major
driver of neuroanatomical defects in the recurrent
16p11.2 deletion and reciprocal duplication, where it can
interact genetically with MVP and MAPK3 (MIM 601795),
and PRRT2 (MIM 614386), which also maps in that CNV,
probably contributes uniquely to the CNV-associated epi-
lepsy.20,72 Similarly, two genes have been implicated in
the etiology of the Williams-Beuren syndrome (MIM
194050), with each gene responsible for a different pheno-
typic component in individuals with the 7q11.23 CNV.
Haploinsufficiency of elastin (ELN [MIM 130160]) is
responsible for the arteriopathies and LIMK-1 (MIM
601329) contributes to the cognitive defects.73–75
Finally, we note that our approach is limited to the
assessment of anatomical phenotypes that have reproduc-
ible, credible surrogates in zebrafish embryos; it is not
currently possible to determine the contribution of
specific genes to cognitive or behavioral defects. Further,
we caution that the phenotypes driven by CNVs are
not necessarily restricted to dosage imbalance for genes
within the CNV; deletions or duplications can have sig-
nificant effects on the regulation of neighboring genes
that are not possible to predict and dissect functionally
at present. Nonetheless, given that a substantial fraction
of CNVs do present with modelable anatomical de-
fects,76 we suggest that unbiased, systematic modeling of
all genes within each discovered CNV will provide insight
into both causality and genetic architecture, while also
providing tools for the initial dissection of the biological
underpinnings of the phenotype. Further insights will be
gained through integration of this CNV modeling data
with genomic sequence data from humans with novel
potentially pathogenic point mutations in the involved
genes.Journal of Human Genetics 93, 798–811, November 7, 2013 807
Supplemental Data
Supplemental Data include five figures and one table and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
We thank Anthony Hinrich and Yangfan Phoebe Liu for technical
assistance. This work was conducted with support from Harvard
Catalyst, The Harvard Clinical and Translational Science Center
(National Institutes of Health Award #UL1 RR 025758 and finan-
cial contributions from Harvard University and its affiliated aca-
demic health care centers). The content is solely the responsibility
of the authors and does not necessarily represent the official views
of Harvard Catalyst, Harvard University, and its affiliated academic
health care centers, the National Center for Research Resources, or
the National Institutes of Health. This work was also supported by
the grant from the Simons Foundation SFARI # 239983 (N.K.) and
the Eunice Kennedy Shriver National Institute of Child Health and
Development grant K23HD073351 (A.D.). S.J. is supported by the
Swiss National Fund professorship grant (PP00P3_144902). N.K. is
a Distinguished Brumley Professor.
Received: August 8, 2013
Revised: September 10, 2013
Accepted: September 16, 2013
Published: October 17, 2013Web Resources






Ensembl Genome Browser, http://www.ensembl.org/index.html
GATK, http://www.broadinstitute.org/gatk/
NCBI, http://www.ncbi.nlm.nih.gov/







UCSC Genome Browser, http://genome.ucsc.eduReferences
1. Iafrate, A.J., Feuk, L., Rivera, M.N., Listewnik, M.L., Donahoe,
P.K., Qi, Y., Scherer, S.W., and Lee, C. (2004). Detection of
large-scale variation in the human genome. Nat. Genet. 36,
949–951.
2. Sebat, J., Lakshmi, B., Troge, J., Alexander, J., Young, J.,
Lundin, P., Ma˚ne´r, S., Massa, H., Walker, M., Chi, M., et al.
(2004). Large-scale copy number polymorphism in the human
genome. Science 305, 525–528.
3. McCarroll, S.A., and Altshuler, D.M. (2007). Copy-number
variation and association studies of human disease. Nat.
Genet. 39(Suppl), S37–S42.808 The American Journal of Human Genetics 93, 798–811, Novemb4. Itsara, A., Wu, H., Smith, J.D., Nickerson, D.A., Romieu, I.,
London, S.J., and Eichler, E.E. (2010). De novo rates and selec-
tion of large copy number variation. Genome Res. 20, 1469–
1481.
5. Cooper, G.M., Coe, B.P., Girirajan, S., Rosenfeld, J.A., Vu, T.H.,
Baker, C., Williams, C., Stalker, H., Hamid, R., Hannig, V., et al.
(2011). A copy number variation morbidity map of develop-
mental delay. Nat. Genet. 43, 838–846.
6. Fakhro, K.A., Choi, M., Ware, S.M., Belmont, J.W., Towbin,
J.A., Lifton, R.P., Khokha, M.K., and Brueckner, M. (2011).
Rare copy number variations in congenital heart disease
patients identify unique genes in left-right patterning. Proc.
Natl. Acad. Sci. USA 108, 2915–2920.
7. Greenway, S.C., Pereira, A.C., Lin, J.C., DePalma, S.R., Israel,
S.J., Mesquita, S.M., Ergul, E., Conta, J.H., Korn, J.M.,
McCarroll, S.A., et al. (2009). De novo copy number variants
identify new genes and loci in isolated sporadic tetralogy of
Fallot. Nat. Genet. 41, 931–935.
8. Osoegawa, K., Vessere, G.M., Utami, K.H., Mansilla, M.A.,
Johnson, M.K., Riley, B.M., L’Heureux, J., Pfundt, R., Staaf,
J., van der Vliet, W.A., et al. (2008). Identification of novel
candidate genes associated with cleft lip and palate using
array comparative genomic hybridisation. J. Med. Genet. 45,
81–86.
9. Sanna-Cherchi, S., Kiryluk, K., Burgess, K.E., Bodria, M., Samp-
son, M.G., Hadley, D., Nees, S.N., Verbitsky, M., Perry, B.J.,
Sterken, R., et al. (2012). Copy-number disorders are a
common cause of congenital kidney malformations. Am. J.
Hum. Genet. 91, 987–997.
10. Scott, D.A., Klaassens, M., Holder, A.M., Lally, K.P., Fernandes,
C.J., Galjaard, R.J., Tibboel, D., de Klein, A., and Lee, B. (2007).
Genome-wide oligonucleotide-based array comparative
genome hybridization analysis of non-isolated congenital
diaphragmatic hernia. Hum. Mol. Genet. 16, 424–430.
11. Serra-Juhe´, C., Rodrı´guez-Santiago, B., Cusco´, I., Vendrell, T.,
Camats, N., Tora´n, N., and Pe´rez-Jurado, L.A. (2012). Contri-
bution of rare copy number variants to isolated human
malformations. PLoS ONE 7, e45530.
12. Brunetti-Pierri, N., Berg, J.S., Scaglia, F., Belmont, J., Bacino,
C.A., Sahoo, T., Lalani, S.R., Graham, B., Lee, B., Shinawi,
M., et al. (2008). Recurrent reciprocal 1q21.1 deletions and
duplications associated with microcephaly or macrocephaly
and developmental and behavioral abnormalities. Nat. Genet.
40, 1466–1471.
13. Coe, B.P., Girirajan, S., and Eichler, E.E. (2012). The genetic
variability and commonality of neurodevelopmental disease.
Am. J. Med. Genet. C. Semin. Med. Genet. 160C, 118–129.
14. Kumar, R.A., KaraMohamed, S., Sudi, J., Conrad, D.F., Brune,
C., Badner, J.A., Gilliam, T.C., Nowak, N.J., Cook, E.H., Jr.,
Dobyns, W.B., and Christian, S.L. (2008). Recurrent 16p11.2
microdeletions in autism. Hum. Mol. Genet. 17, 628–638.
15. McCarthy, S.E., Makarov, V., Kirov, G., Addington, A.M.,
McClellan, J., Yoon, S., Perkins, D.O., Dickel, D.E., Kusenda,
M., Krastoshevsky, O., et al.; Wellcome Trust Case Control
Consortium. (2009). Microduplications of 16p11.2 are associ-
ated with schizophrenia. Nat. Genet. 41, 1223–1227.
16. Sanders, S.J., Ercan-Sencicek, A.G., Hus, V., Luo, R., Murtha,
M.T., Moreno-De-Luca, D., Chu, S.H., Moreau, M.P., Gupta,
A.R., Thomson, S.A., et al. (2011). Multiple recurrent de
novo CNVs, including duplications of the 7q11.23 Williams
syndrome region, are strongly associated with autism. Neuron
70, 863–885.er 7, 2013
17. Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C.,
Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al.
(2007). Strong association of de novo copy number mutations
with autism. Science 316, 445–449.
18. Stefansson, H., Rujescu, D., Cichon, S., Pietila¨inen, O.P., Inga-
son, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson,
T., Buizer-Voskamp, J.E., et al.; GROUP. (2008). Large recurrent
microdeletions associated with schizophrenia. Nature 455,
232–236.
19. Weiss, L.A., Shen, Y., Korn, J.M., Arking, D.E., Miller, D.T.,
Fossdal, R., Saemundsen, E., Stefansson, H., Ferreira, M.A.,
Green, T., et al.; Autism Consortium. (2008). Association
between microdeletion and microduplication at 16p11.2
and autism. N. Engl. J. Med. 358, 667–675.
20. Golzio, C., Willer, J., Talkowski, M.E., Oh, E.C., Taniguchi, Y.,
Jacquemont, S., Reymond, A., Sun, M., Sawa, A., Gusella, J.F.,
et al. (2012). KCTD13 is a major driver of mirrored neuroana-
tomical phenotypes of the 16p11.2 copy number variant.
Nature 485, 363–367.
21. Horev, G., Ellegood, J., Lerch, J.P., Son, Y.E., Muthuswamy, L.,
Vogel, H., Krieger, A.M., Buja, A., Henkelman, R.M., Wigler,
M., and Mills, A.A. (2011). Dosage-dependent phenotypes in
models of 16p11.2 lesions found in autism. Proc. Natl. Acad.
Sci. USA 108, 17076–17081.
22. Lacaria, M., Saha, P., Potocki, L., Bi, W., Yan, J., Girirajan, S.,
Burns, B., Elsea, S., Walz, K., Chan, L., et al. (2012). A duplica-
tion CNV that conveys traits reciprocal to metabolic
syndrome and protects against diet-induced obesity in mice
and men. PLoS Genet. 8, e1002713.
23. Liao, J., Kochilas, L., Nowotschin, S., Arnold, J.S., Aggarwal,
V.S., Epstein, J.A., Brown, M.C., Adams, J., and Morrow, B.E.
(2004). Full spectrum of malformations in velo-cardio-facial
syndrome/DiGeorge syndrome mouse models by altering
Tbx1 dosage. Hum. Mol. Genet. 13, 1577–1585.
24. Walz, K., Caratini-Rivera, S., Bi, W., Fonseca, P., Mansouri,
D.L., Lynch, J., Vogel, H., Noebels, J.L., Bradley, A., and
Lupski, J.R. (2003). Modeling del(17)(p11.2p11.2) and
dup(17)(p11.2p11.2) contiguous gene syndromes by chromo-
some engineering in mice: phenotypic consequences of gene
dosage imbalance. Mol. Cell. Biol. 23, 3646–3655.
25. Yan, J., Keener, V.W., Bi, W., Walz, K., Bradley, A., Justice, M.J.,
and Lupski, J.R. (2004). Reduced penetrance of craniofacial
anomalies as a function of deletion size and genetic back-
ground in a chromosome engineered partial mouse model for
Smith-Magenis syndrome. Hum. Mol. Genet. 13, 2613–2624.
26. Tomlinson, I.P., Webb, E., Carvajal-Carmona, L., Broderick, P.,
Howarth, K., Pittman, A.M., Spain, S., Lubbe, S., Walther, A.,
Sullivan, K., et al.; CORGI Consortium; EPICOLON Con-
sortium. (2008). A genome-wide association study identifies
colorectal cancer susceptibility loci on chromosomes 10p14
and 8q23.3. Nat. Genet. 40, 623–630.
27. Talseth-Palmer, B.A., Scott, R.J., Vasen, H.F., and Wijnen, J.T.
(2012). 8q23.3 and 11q23.1 as modifying loci influencing
the risk for CRC in Lynch syndrome. Eur. J. Hum. Genet. 20,
487–488, author reply 488.
28. Mikami, M., Yasuda, T., Terao, A., Nakamura, M., Ueno, S.,
Tanabe, H., Tanaka, T., Onuma, T., Goto, Y., Kaneko, S., and
Sano, A. (1999). Localization of a gene for benign adult famil-
ial myoclonic epilepsy to chromosome 8q23.3-q24.1. Am. J.
Hum. Genet. 65, 745–751.
29. Halevy, A., Basel-Vanagaite, L., Shuper, A., Helman, S., Har-
Zahav, A., Birk, E., Maya, I., Kornreich, L., Inbar, D., Nu¨rnberg,The AmericanG., et al. (2012). Microcephaly-thin corpus callosum syn-
drome maps to 8q23.2-q24.12. Pediatr. Neurol. 46, 363–368.
30. Yamamoto, Y., Oguro, N., Miyao, M., and Yanagisawa, M.
(1989). Tricho-rhino-phalangeal syndrome type I with severe
mental retardation due to interstitial deletion of 8q23.3-
24.13. Am. J. Med. Genet. 32, 133–135.
31. Naritomi, K., and Hirayama, K. (1989). Partial trisomy of distal
8q derived from mother with mosaic 8q23.3——24.13 dele-
tion, and relatively mild expression of trichorhinophalangeal
syndrome I. Hum. Genet. 82, 199–201.
32. Stengel-Rutkowski, S., Lohse, K., Herzog, C., Apacik, C.,
Couturier, J., Albert, A., and Belohradsky, B. (1992). Partial
trisomy 8q. Two case reports with maternal translocation
and inverted insertion: phenotype analyses and reflections
on the risk. Clin. Genet. 42, 178–185.
33. Wheeler, P.G. (2010). 8q23-q24 duplication—further delinea-
tion of a rare chromosomal abnormality. Am. J. Med. Genet.
A. 152A, 459–463.
34. Bu¨hler, E.M., Bu¨hler, U.K., Beutler, C., and Fessler, R. (1987). A
final word on the tricho-rhino-phalangeal syndromes. Clin.
Genet. 31, 273–275.
35. Shanske, A.L., Patel, A., Saukam, S., Levy, B., and Lu¨decke,
H.J. (2008). Clinical and molecular characterization of a
patient with Langer-Giedion syndrome and mosaic
del(8)(q22.3q24.13). Am. J. Med. Genet. A. 146A, 3211–
3216.
36. Wuyts, W., Roland, D., Lu¨decke, H.J., Wauters, J., Foulon, M.,
Van Hul, W., and Van Maldergem, L. (2002). Multiple exosto-
ses, mental retardation, hypertrichosis, and brain abnormal-
ities in a boy with a de novo 8q24 submicroscopic interstitial
deletion. Am. J. Med. Genet. 113, 326–332.
37. Verheij, J.B., de Munnik, S.A., Dijkhuizen, T., de Leeuw, N.,
Olde Weghuis, D., van den Hoek, G.J., Rijlaarsdam, R.S.,
Thomasse, Y.E., Dikkers, F.G., Marcelis, C.L., et al. (2009). An
8.35 Mb overlapping interstitial deletion of 8q24 in two
patients with coloboma, congenital heart defect, limb abnor-
malities, psychomotor retardation and convulsions. Eur. J.
Hum. Genet. 52, 353–357.
38. Beunders, G., Voorhoeve, E., Golzio, C., Pardo, L.M., Rose-
nfeld, J.A., Talkowski, M.E., Simonic, I., Lionel, A.C.,
Vergult, S., Pyatt, R.E., et al. (2013). Exonic deletions in
AUTS2 cause a syndromic form of intellectual disability
and suggest a critical role for the C terminus. Am. J. Hum.
Genet. 92, 210–220.
39. Hastings, M.L., Allemand, E., Duelli, D.M., Myers, M.P., and
Krainer, A.R. (2007). Control of pre-mRNA splicing by the
general splicing factors PUF60 and U2AF(65). PLoS ONE 2,
e538.
40. Dauber, A., Stoler, J., Hechter, E., Safer, J., and Hirschhorn, J.N.
(2013). Whole exome sequencing reveals a novel mutation in
CUL7 in a patient with an undiagnosed growth disorder.
J. Pediatr. 162, 202–204, e1.
41. Bicknell, L.S., Walker, S., Klingseisen, A., Stiff, T., Leitch, A.,
Kerzendorfer, C., Martin, C.A., Yeyati, P., Al Sanna, N., Bober,
M., et al. (2011). Mutations in ORC1, encoding the largest
subunit of the origin recognition complex, cause microce-
phalic primordial dwarfism resembling Meier-Gorlin
syndrome. Nat. Genet. 43, 350–355.
42. Kuo, A.J., Song, J., Cheung, P., Ishibe-Murakami, S., Yamazoe,
S., Chen, J.K., Patel, D.J., and Gozani, O. (2012). The BAH
domain of ORC1 links H4K20me2 to DNA replication
licensing and Meier-Gorlin syndrome. Nature 484, 115–119.Journal of Human Genetics 93, 798–811, November 7, 2013 809
43. Margolin, D.H., Kousi, M., Chan, Y.M., Lim, E.T., Schmah-
mann, J.D., Hadjivassiliou, M., Hall, J.E., Adam, I., Dwyer,
A., Plummer, L., et al. (2013). Ataxia, dementia, and hypogo-
nadotropism caused by disordered ubiquitination. N. Engl. J.
Med. 368, 1992–2003.
44. Ross, A.J., May-Simera, H., Eichers, E.R., Kai, M., Hill, J., Jagger,
D.J., Leitch, C.C., Chapple, J.P., Munro, P.M., Fisher, S., et al.
(2005). Disruption of Bardet-Biedl syndrome ciliary proteins
perturbs planar cell polarity in vertebrates. Nat. Genet. 37,
1135–1140.
45. Sarparanta, J., Jonson, P.H., Golzio, C., Sandell, S., Luque, H.,
Screen, M., McDonald, K., Stajich, J.M., Mahjneh, I., Vihola,
A., et al. (2012). Mutations affecting the cytoplasmic func-
tions of the co-chaperone DNAJB6 cause limb-girdle muscular
dystrophy. Nat. Genet. 44, 450–455, S1–S2.
46. Zaghloul, N.A., Liu, Y., Gerdes, J.M., Gascue, C., Oh, E.C.,
Leitch, C.C., Bromberg, Y., Binkley, J., Leibel, R.L., Sidow, A.,
et al. (2010). Functional analyses of variants reveal a signifi-
cant role for dominant negative and common alleles in oligo-
genic Bardet-Biedl syndrome. Proc. Natl. Acad. Sci. USA 107,
10602–10607.
47. Santoriello, C., and Zon, L.I. (2012). Hooked! Modeling
human disease in zebrafish. J. Clin. Invest. 122, 2337–2343.
48. Doelken, S.C., Ko¨hler, S., Mungall, C.J., Gkoutos, G.V., Ruef,
B.J., Smith, C., Smedley, D., Bauer, S., Klopocki, E., Scho-
field, P.N., et al. (2013). Phenotypic overlap in the contribu-
tion of individual genes to CNV pathogenicity revealed by
cross-species computational analysis of single-gene muta-
tions in humans, mice and zebrafish. Dis. Model. Mech. 6,
358–372.
49. Hentschel, D.M., Mengel, M., Boehme, L., Liebsch, F., Alber-
tin, C., Bonventre, J.V., Haller, H., and Schiffer, M. (2007).
Rapid screening of glomerular slit diaphragm integrity in
larval zebrafish. Am. J. Physiol. Renal Physiol. 293, F1746–
F1750.
50. Hentschel, D.M., Park, K.M., Cilenti, L., Zervos, A.S., Drum-
mond, I., and Bonventre, J.V. (2005). Acute renal failure in
zebrafish: a novel system to study a complex disease. Am. J.
Physiol. Renal Physiol. 288, F923–F929.
51. Bakkers, J. (2011). Zebrafish as a model to study cardiac devel-
opment and human cardiac disease. Cardiovasc. Res. 91,
279–288.
52. Mitchell, I.C., Brown, T.S., Terada, L.S., Amatruda, J.F., and
Nwariaku, F.E. (2010). Effect of vascular cadherin knockdown
on zebrafish vasculature during development. PLoS ONE 5,
e8807.
53. Qu, X., Jia, H., Garrity, D.M., Tompkins, K., Batts, L., Appel, B.,
Zhong, T.P., and Baldwin, H.S. (2008). Ndrg4 is required for
normal myocyte proliferation during early cardiac develop-
ment in zebrafish. Dev. Biol. 317, 486–496.
54. Sun, X., Zhang, R., Lin, X., and Xu, X. (2008). Wnt3a regulates
the development of cardiac neural crest cells by modulating
expression of cysteine-rich intestinal protein 2 in rhombo-
mere 6. Circ. Res. 102, 831–839.
55. Pieczynski, J., and Margolis, B. (2011). Protein complexes that
control renal epithelial polarity. Am. J. Physiol. Renal Physiol.
300, F589–F601.
56. Yates, L.L., Schnatwinkel, C., Hazelwood, L., Chessum, L.,
Paudyal, A., Hilton, H., Romero, M.R., Wilde, J., Bogani, D.,
Sanderson, J., et al. (2013). Scribble is required for normal
epithelial cell-cell contacts and lumen morphogenesis in the
mammalian lung. Dev. Biol. 373, 267–280.810 The American Journal of Human Genetics 93, 798–811, Novemb57. Michaelis, U.R., Chavakis, E., Kruse, C., Jungblut, B., Kaluza,
D., Wandzioch, K., Manavski, Y., Heide, H., Santoni, M.J.,
Potente,M., et al. (2013). The polarity protein Scrib is essential
for directed endothelial cellmigration.Circ. Res.112, 924–934.
58. Skouloudaki, K., Puetz, M., Simons, M., Courbard, J.R.,
Boehlke, C., Hartleben, B., Engel, C., Moeller, M.J., Englert,
C., Bollig, F., et al. (2009). Scribble participates in Hippo
signaling and is required for normal zebrafish pronephros
development. Proc. Natl. Acad. Sci. USA 106, 8579–8584.
59. Courbard, J.R., Djiane, A., Wu, J., andMlodzik, M. (2009). The
apical/basal-polarity determinant Scribble cooperates with the
PCP core factor Stbm/Vang and functions as one of its effec-
tors. Dev. Biol. 333, 67–77.
60. Burns, C.J., Zhang, J., Brown, E.C., Van Bibber, A.M., Van Es, J.,
Clevers, H., Ishikawa, T.O., Taketo, M.M., Vetter, M.L., and
Fuhrmann, S. (2008). Investigation of Frizzled-5 during
embryonic neural development in mouse. Dev. Dyn. 237,
1614–1626.
61. Liu, C., Bakeri, H., Li, T., and Swaroop, A. (2012). Regulation of
retinal progenitor expansion by Frizzled receptors: implica-
tions for microphthalmia and retinal coloboma. Hum. Mol.
Genet. 21, 1848–1860.
62. Liu, H., Xu, S., Wang, Y., Mazerolle, C., Thurig, S., Coles, B.L.,
Ren, J.C., Taketo, M.M., van der Kooy, D., and Wallace, V.A.
(2007). Ciliary margin transdifferentiation from neural retina
is controlled by canonical Wnt signaling. Dev. Biol. 308,
54–67.
63. Zhou, C.J., Molotkov, A., Song, L., Li, Y., Pleasure, D.E., Plea-
sure, S.J., and Wang, Y.Z. (2008). Ocular coloboma and dorso-
ventral neuroretinal patterning defects in Lrp6 mutant eyes.
Dev. Dyn. 237, 3681–3689.
64. Roche, J.P., Packard, M.C., Moeckel-Cole, S., and Budnik, V.
(2002). Regulation of synaptic plasticity and synaptic vesicle
dynamics by the PDZ protein Scribble. J. Neurosci. 22, 6471–
6479.
65. Osmani, N., Vitale, N., Borg, J.P., and Etienne-Manneville, S.
(2006). Scrib controls Cdc42 localization and activity to
promote cell polarization during astrocyte migration. Curr.
Biol. 16, 2395–2405.
66. Gordon, C.T., Petit, F., Oufadem, M., Decaestecker, C., Jour-
dain, A.S., Andrieux, J., Malan, V., Alessandri, J.L., Baujat,
G., Baumann, C., et al. (2012). EFTUD2 haploinsufficiency
leads to syndromic oesophageal atresia. J. Med. Genet. 49,
737–746.
67. Lines, M.A., Huang, L., Schwartzentruber, J., Douglas, S.L.,
Lynch, D.C., Beaulieu, C., Guion-Almeida, M.L., Zechi-
Ceide, R.M., Gener, B., Gillessen-Kaesbach, G., et al.; FORGE
Canada Consortium. (2012). Haploinsufficiency of a spliceo-
somal GTPase encoded by EFTUD2 causes mandibulofacial
dysostosis with microcephaly. Am. J. Hum. Genet. 90,
369–377.
68. Luquetti, D.V., Hing, A.V., Rieder, M.J., Nickerson, D.A.,
Turner, E.H., Smith, J., Park, S., and Cunningham, M.L.
(2013). ‘‘Mandibulofacial dysostosis with microcephaly’’
caused by EFTUD2 mutations: expanding the phenotype.
Am. J. Med. Genet. A. 161A, 108–113.
69. Bernier, F.P., Caluseriu, O., Ng, S., Schwartzentruber, J., Buck-
ingham, K.J., Innes, A.M., Jabs, E.W., Innis, J.W., Schuette,
J.L., Gorski, J.L., et al.; FORGE Canada Consortium. (2012).
Haploinsufficiency of SF3B4, a component of the pre-mRNA
spliceosomal complex, causes Nager syndrome. Am. J. Hum.
Genet. 90, 925–933.er 7, 2013
70. Champion-Arnaud, P., and Reed, R. (1994). The prespliceo-
some components SAP 49 and SAP 145 interact in a complex
implicated in tethering U2 snRNP to the branch site. Genes
Dev. 8, 1974–1983.
71. Van Buskirk, C., and Schu¨pbach, T. (2002). Half pint regulates
alternative splice site selection in Drosophila. Dev. Cell 2,
343–353.
72. Labate, A., Tarantino, P., Palamara, G., Gagliardi, M., Caval-
canti, F., Ferlazzo, E., Sturniolo, M., Incorpora, G., Annesi,
G., Aguglia, U., and Gambardella, A. (2013). Mutations in
PRRT2 result in familial infantile seizures with heterogeneous
phenotypes including febrile convulsions and probable
SUDEP. Epilepsy Res. 104, 280–284.
73. Delio, M., Pope, K.,Wang, T., Samanich, J., Haldeman-Englert,
C.R., Kaplan, P., Shaikh, T.H., Cai, J., Marion, R.W., Morrow,
B.E., and Babcock, M. (2013). Spectrum of elastin sequenceThe Americanvariants and cardiovascular phenotypes in 49 patients with
Williams-Beuren syndrome. Am. J. Med. Genet. A. 161A,
527–533.
74. Frangiskakis, J.M., Ewart, A.K., Morris, C.A., Mervis, C.B.,
Bertrand, J., Robinson, B.F., Klein, B.P., Ensing, G.J., Everett,
L.A., Green, E.D., et al. (1996). LIM-kinase1 hemizygosity
implicated in impaired visuospatial constructive cognition.
Cell 86, 59–69.
75. Micale, L., Turturo, M.G., Fusco, C., Augello, B., Jurado, L.A.,
Izzi, C., Digilio, M.C., Milani, D., Lapi, E., Zelante, L., and
Merla, G. (2010). Identification and characterization of seven
novelmutations of elastin gene in a cohort of patients affected
by supravalvular aortic stenosis. Eur. J. Hum. Genet. 18,
317–323.
76. Golzio, C., and Katsanis, N. (2013). Genetic architecture of
reciprocal CNVs. Curr. Opin. Genet. Dev. 23, 240–248.Journal of Human Genetics 93, 798–811, November 7, 2013 811
